EIP to host One Nucleus BioWednesday

EIP will host a One Nucleus BioWednesday seminar entitled ‘Managing IP Litigation on a Budget’.

The event takes place at EIP’s London office on 3 July from 6pm and registration is open to all members of the One Nucleus life sciences network.

The seminar will explore the ways in which companies can control their costs in litigation and also secure greater certainty as to the level of exposure. It will feature specialist litigation solicitors, including in-house Counsel with significant experience in conducting high profile litigation cases in multiple jurisdictions.

Further details of the programme including the expert speakers, is available on the One Nucleus website.

JIPLP: So when is a patent claim too broad?

The Journal of Intellectual Property Law and Practice has published an article by Andrew Sharples and Carissa Kendall-Palmer about the Court of Appeal’s decision in Regeneron Pharmaceuticals Inc v Genentech Inc. This ruling confirms that a broad claim...

The legality of ‘reverse payments’ in the EU

In a guest post for the Spicy IP blog, partner Gary Moss discusses the practice of ‘reverse payments’, where a pharmaceutical company, which owns a patent, pays off a generic competitor to not enter the market. It follows fines totalling €146 Million ...

Design drawings: more than meets the eye

A recent judgment handed down by Mr Justice Birss in Sealed Air Ltd v Sharp Interpack Ltd & Anor [2013] EWPCC 23 (30 May 2013) considers the way in which technical drawings in a registered design should be interpreted. In effect, Birss J...

Compulsory licences: necessity or threat?

In an opinion article for Chemistry World, Darren Smyth joins five other international experts on the subject in giving his view on whether compulsory licences for patent-protected drugs are a necessary measure, or a threat to innovation.

EIP to host One Nucleus BioWednesday

Our cookies

Essential

Analytics

Social media & third party